Your session is about to expire
← Back to Search
Leukapheresis for Sarcoma (NYESO SCT Trial)
NYESO SCT Trial Summary
This trial is testing a new cancer treatment that replaces a patient's immune system with new cells that have been redirected to attack and kill cancer cells.
- Sarcoma
- Malignant Neoplasm
- Cancer
- Malignant Tumor
- HLA-A2 Positive Cells Present
NYESO SCT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNYESO SCT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NYESO SCT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have an advanced cancer that cannot be removed by surgery and no other proven treatment options are available.
- Group 1: Treatment (Genetically engineered PBMC and PBSC)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the aggregate size of this research project's participants?
"Yes, the clinicaltrials.gov portal confirms that this medical study is searching for 12 participants from 1 trial site. The listing was first uploaded on July 26th 2017 and last modified on February 10th 2022."
What health issues can be addressed through Cellular Therapy?
"Mobilization of hematopoietic stem cells is generally treated with Cellular Therapy, a method that has also been employed to manage bone marrow transplantation, leukemia and febrile neutropenia."
What precedent is there for Cellular Therapy research?
"Presently, 563 Cell Therapy trials are underway. Of these, 62 have progressed to the third phase of clinical research. The majority of studies take place in Philadelphia, but 8628 other locations also conduct similar trials for this form of treatment."
Can individuals still join this experiment?
"Indeed, the statistics on clinicaltrials.gov reveal that this medical research is actively recruiting individuals. This trial was initially posted in July 2017 and most recently updated in February 2022; 12 patients must be recruited from 1 centre."
Has the Food & Drug Administration sanctioned Cellular Therapy?
"With limited evidence for both safety and efficacy, Cellular Therapy receives a score of 1."
Share this study with friends
Copy Link
Messenger